VISUAL THRESHOLDS TO LOW-CONTRAST PATTERN DISPLACEMENT, COLOR CONTRAST, AND LUMINANCE CONTRAST STIMULI IN PARKINSONS-DISEASE

被引:51
作者
HAUG, BA
TRENKWALDER, C
ARDEN, GB
OERTEL, WH
PAULUS, W
机构
[1] UNIV GOTTINGEN, DEPT CLIN NEUROPHYSIOL, GOTTINGEN, GERMANY
[2] MAX PLANCK INST PSYCHIAT, CLIN INST NEUROL, MUNICH, GERMANY
[3] MOORFIELDS EYE HOSP, INST OPHTHALMOL, LONDON, ENGLAND
[4] UNIV MUNICH, DEPT NEUROL, W-8000 MUNICH, GERMANY
关键词
PARKINSONS DISEASE; VISUAL THRESHOLDS; DISPLACEMENT STIMULI; COLOR CONTRAST; LUMINANCE CONTRAST;
D O I
10.1002/mds.870090510
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We used the computerized Moorfield Vision System to demonstrate specific increases in various perceptual visual thresholds in idiopathic Parkinson's syndrome. Fifteen patients were compared to 13 age-matched normals. Motion detection was impaired maximally (2p < 0.01 and better in two-tailed t test) at luminance contrasts of 3-7%. Stimulus was an achromatic vertical 4 cycles/degrees sine wave grating subtending 3 degrees x 2 degrees, centered 5 degrees in the nasal field and oscillating at 5 Hz. In addition, stationary color and luminance contrast thresholds were tested with flashed display of 5 degrees x 6 degrees random letters, which were presented for 200 ms (color) and 50 ms (achromatic). Color discrimination was impaired in the tritan axis only (2p < 0.05 in two-tailed t test). All achromatic stimuli-luminance increments, decrements, and phase reversing stimuli-were equally well seen by patients and controls. We conclude that the dopaminergic deficit of retinal amacrine cells in Parkinson patients can be monitored by combined low-contrast and motion (displacement) stimuli. Future studies will determine if moving colored targets are more effective in discriminating patients from controls than are the achromatic gratings used in this work.
引用
收藏
页码:563 / 570
页数:8
相关论文
共 41 条
[1]   COLOR-VISION TESTING WITH A COMPUTER-GRAPHICS SYSTEM - PRELIMINARY-RESULTS [J].
ARDEN, G ;
GUNDUZ, K ;
PERRY, S .
DOCUMENTA OPHTHALMOLOGICA, 1988, 69 (02) :167-174
[2]  
Bodis-Wollner I, 1983, J Neural Transm Suppl, V19, P243
[3]   VISUAL DYSFUNCTION IN PARKINSONS-DISEASE - LOSS IN SPATIOTEMPORAL CONTRAST SENSITIVITY [J].
BODISWOLLNER, I ;
MARX, MS ;
MITRA, S ;
BOBAK, P ;
MYLIN, L ;
YAHR, M .
BRAIN, 1987, 110 :1675-1698
[4]   EFFECT OF LEVODOPA TREATMENT ON CONTRAST SENSITIVITY IN PARKINSONS-DISEASE [J].
BULENS, C ;
MEERWALDT, JD ;
VANDERWILDT, GJ ;
VANDEURSEN, JBP .
ANNALS OF NEUROLOGY, 1987, 22 (03) :365-369
[5]   CONTRAST SENSITIVITY IN PARKINSONS-DISEASE [J].
BULENS, C ;
MEERWALDT, JD ;
VANDERWILDT, GJ ;
KEEMINK, CJ .
NEUROLOGY, 1986, 36 (08) :1121-1125
[6]   TILT AFTEREFFECT REVEALS EARLY VISUAL PROCESSING DEFICITS IN PARKINSONS-DISEASE AND IN CHRONIC-SCHIZOPHRENIC PATIENTS ON DEPOT NEUROLEPTIC [J].
CALVERT, JE ;
HARRIS, JP ;
PHILLIPSON, OT .
PSYCHOPATHOLOGY, 1991, 24 (06) :375-380
[7]  
COMERFORD JP, 1991, NEWENCO RES SERIES, P1
[8]  
CORBE C, 1992, J NEUROL, V239, pS22
[9]   THE DOPAMINERGIC AMACRINE CELL [J].
DACEY, DM .
JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 301 (03) :461-489
[10]  
DELWAIDE P-J, 1980, Revue d'Electroencephalographie et de Neurophysiologie Clinique, V10, P338, DOI 10.1016/S0370-4475(80)80031-1